Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Drug Screening Market
Drug Screening Market Size
- Report ID: GMI5971
- Published Date: Jun 2023
- Report Format: PDF
Drug Screening Market Size
Drug Screening Market size was valued at USD 6.2 billion in 2022 and is expected to reach USD 27.1 billion by 2032, registering a CAGR of 16.3% during the forecast period. Growth can be attributed to the surging consumption of drugs and alcohol across the globe that has accelerated the adoption of drug screening.
According to the World Drug Report 2021, drug use disorders were estimated to affect 36.3 million people worldwide in 2019. Thus, rising drug use disorder across the globe is expected to increase the product demand. Further, enforcement of stringent laws to curb drug and alcohol usage, strict laws on drug screening, and rising regulatory approvals of novel drug screening products are few of the factors that positively influencing the market revenue.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Drug Screening Market Size in 2022: | USD 6.2 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 16.3% |
| 2032 Value Projection: | USD 27.1 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 210 |
| Tables, Charts & Figures: | 384 |
| Segments covered: | Components, Sample Type, Drug Type, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Drug screening test basically analyses biological samples such as urine, oral fluids, hair, and breath samples to determine the presence of drug abuse or its metabolites in patient’s body. Drug screening tests are used to determine whether a person is or was under the influence of drugs at any given time.
Frequently Asked Questions (FAQ) :
Drug Screening Market Scope
